Search Results - "Keeho Song"
-
1
Beyond Acute COVID-19: Investigating the Incidence of Subacute Thyroiditis in Long COVID-19 in Korea
Published in Endocrinology and metabolism (Seoul) (01-08-2023)“…The correlation between acute coronavirus disease 2019 (COVID-19) and subacute thyroiditis (SAT) has not been clearly investigated in "long COVID" patients. We…”
Get full text
Journal Article -
2
Risk for Newly Diagnosed Type 2 Diabetes Mellitus after COVID-19 among Korean Adults: A Nationwide Matched Cohort Study
Published in Endocrinology and metabolism (Seoul) (01-04-2023)“…Coronavirus disease 2019 (COVID-19) can cause various extrapulmonary sequelae, including diabetes. However, it is unclear whether these effects persist 30 days…”
Get full text
Journal Article -
3
Beyond Acute COVID-19: Investigating the Incidence of Subacute Thyroiditis in Long COVID-19 in Korea
Published in Endocrinology and metabolism (Seoul) (31-08-2023)“…Background: The correlation between acute coronavirus disease 2019 (COVID-19) and subacute thyroiditis (SAT) has not been clearly investigated in “long COVID”…”
Get full text
Journal Article -
4
Mortality and Severity of Coronavirus Disease 2019 in Patients with Long-Term Glucocorticoid Therapy: A Korean Nationwide Cohort Study
Published in Endocrinology and metabolism (Seoul) (01-04-2023)“…The severity of coronavirus disease 2019 (COVID-19) among patients with long-term glucocorticoid treatment (LTGT) has not been established. We aimed to…”
Get full text
Journal Article -
5
Real-World Treatment Patterns according to Clinical Practice Guidelines in Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Korea: Multicenter, Retrospective, Observational Study
Published in Diabetes & metabolism journal (01-03-2024)“…Recent diabetes management guidelines recommend that sodium-glucose cotransporter 2 inhibitors (SGLT2is) or glucagon-like peptide 1 receptor agonists…”
Get full text
Journal Article -
6
Efficacy of Gemigliptin Add-on to Dapagliflozin and Metformin in Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo-Controlled Study (SOLUTION)
Published in Endocrinology and metabolism (Seoul) (01-06-2023)“…This study evaluated the efficacy and safety of add-on gemigliptin in patients with type 2 diabetes mellitus (T2DM) who had inadequate glycemic control with…”
Get full text
Journal Article -
7
Risk for Newly Diagnosed Type 2 Diabetes Mellitus after COVID-19 among Korean Adults: A Nationwide Matched Cohort Study
Published in Endocrinology and metabolism (Seoul) (30-04-2023)“…Background: Coronavirus disease 2019 (COVID-19) can cause various extrapulmonary sequelae, including diabetes. However, it is unclear whether these effects…”
Get full text
Journal Article -
8
Mortality and Severity of Coronavirus Disease 2019 in Patients with Long-Term Glucocorticoid Therapy: A Korean Nationwide Cohort Study
Published in Endocrinology and metabolism (Seoul) (30-04-2023)“…Background: The severity of coronavirus disease 2019 (COVID-19) among patients with long-term glucocorticoid treatment (LTGT) has not been established. We…”
Get full text
Journal Article -
9
Real-World Treatment Patterns according to Clinical Practice Guidelines in Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Korea: Multicenter, Retrospective, Observational Study
Published in Diabetes & metabolism journal (31-03-2024)“…Background: Recent diabetes management guidelines recommend that sodium-glucose cotransporter 2 inhibitors (SGLT2is) or glucagon-like peptide 1 receptor…”
Get full text
Journal Article -
10
Efficacy of Gemigliptin Add-on to Dapagliflozin and Metformin in Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo-Controlled Study (SOLUTION)
Published in Endocrinology and metabolism (Seoul) (30-06-2023)“…Background: This study evaluated the efficacy and safety of add-on gemigliptin in patients with type 2 diabetes mellitus (T2DM) who had inadequate glycemic…”
Get full text
Journal Article -
11
Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate- Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE)
Published in Endocrinology and metabolism (Seoul) (31-10-2024)“…Background: Atherogenic dyslipidemia, which is frequently associated with type 2 diabetes (T2D) and insulin resistance, contributes to the development of…”
Get full text
Journal Article -
12
Adrenalectomy Improves Body Weight, Glucose, and Blood Pressure Control in Patients with Mild Autonomous Cortisol Secretion: Results of an RCT by the Co-work of Adrenal Research (COAR) Study
Published in Annals of surgery (21-12-2023)“…Objective: To assess the metabolic effects of adrenalectomy in patients with mild autonomous cortisol secretion (MACS). Background: Despite retrospective…”
Get full text
Journal Article -
13
Adrenalectomy Improves Body Weight, Glucose, and Blood Pressure Control in Patients With Mild Autonomous Cortisol Secretion: Results of an Randomized Controlled Trial by the Co-work of Adrenal Research (COAR) Study
Published in Annals of surgery (01-06-2024)“…To assess the metabolic effects of adrenalectomy in patients with mild autonomous cortisol secretion (MACS). Despite retrospective studies showing the…”
Get full text
Journal Article -
14
Pituitary Diseases and COVID-19 Outcomes in South Korea: A Nationwide Cohort Study
Published in Journal of clinical medicine (20-07-2023)“…The pituitary gland is either directly or indirectly impacted by SARS-CoV-2 infection. As a consequence of SARS-CoV-2 infection, hypothalamic-pituitary…”
Get full text
Journal Article -
15
IL-32γ overexpression accelerates streptozotocin (STZ)-induced type 1 diabetes
Published in Cytokine (Philadelphia, Pa.) (01-09-2014)“…•Mouse model of STZ-induced type 1 diabetes was aggravated in IL-32γ TG mice.•Spontaneous elevation of inflammatory cytokines in pancreas of IL-32γ TG…”
Get full text
Journal Article -
16
Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE)
Published in Endocrinology and metabolism (Seoul) (01-10-2024)“…Atherogenic dyslipidemia, which is frequently associated with type 2 diabetes (T2D) and insulin resistance, contributes to the development of vascular…”
Get full text
Journal Article -
17
Neutrophil Proteinase 3 Induces Diabetes in a Mouse Model of Glucose Tolerance
Published in Endocrine research (01-02-2012)“…Type 1 diabetes is considered to be an autoimmune disease in which T cells attack pancreatic islet cells. Impaired glucose tolerance with type 2 diabetes has…”
Get full text
Journal Article